Status:
COMPLETED
The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Atherosclerosis
Eligibility:
MALE
40-85 years
Phase:
PHASE2
Brief Summary
A study to test the effects of study drug (MK 0633) on patients with Atherosclerotic disease
Eligibility Criteria
Inclusion
- Patients with plaque in coronary or leg arteries, known as atherosclerosis or peripheral vascular disease
- Inflammatory marker found in your blood, known as hsCRP \> 0.5 mg/L
Exclusion
- Age \< 40 or \> 85
- Female
- Heart attack, coronary artery bypass, stroke or unstable angina in last 3 months
- Liver diseased or abnormalities
- HIV infection
- Lupus, rheumatoid arthritis, cancer \<5 years
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00421278
Start Date
November 1 2006
End Date
January 1 2007
Last Update
January 22 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.